Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2016, Article ID 9029606, 3 pages
http://dx.doi.org/10.1155/2016/9029606
Case Report

The Role of TEE in Diagnosing Hepatopulmonary Syndrome and Cryptogenic Cirrhosis

1Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada
2Department of Internal Medicine, University of British Columbia, Surrey, BC, Canada
3Section of Cardiology, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada
4Institute of Cardiovascular Sciences, St. Boniface General Hospital, University of Manitoba, Winnipeg, MB, Canada
5Department of Radiology, St. Boniface General Hospital, University of Manitoba, Winnipeg, MB, Canada

Received 10 July 2016; Accepted 17 August 2016

Academic Editor: Saadeh Al-Jureidini

Copyright © 2016 Joel Scott-Herridge et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Schenk, M. Schöniger-Hekele, V. Fuhrmann, C. Madl, G. Silberhumer, and C. Müller, “Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis,” Gastroenterology, vol. 125, no. 4, pp. 1042–1052, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Krowka, E. R. Dickson, and D. A. Cortese, “Hepatopulmonary syndrome: clinical observations and lack of therapeutic response to somatostatin analogue,” Chest, vol. 104, no. 2, pp. 515–521, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Andrivet, J. Cadranel, B. Housset, R. Herigault, A. Harf, and S. Adnot, “Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency. Effects of indomethacin,” Chest, vol. 103, no. 2, pp. 500–507, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. T. D. Woods and A. Patel, “A critical review of patent foramen ovale detection using saline contrast echocardiography: when bubbles lie,” Journal of the American Society of Echocardiography, vol. 19, no. 2, pp. 215–222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Nanthakumar, A. T. Graham, T. I. Robinson et al., “Contrast echocardiography for detection of pulmonary arteriovenous malformations,” American Heart Journal, vol. 141, no. 2, pp. 243–246, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. W. F. van Gent, M. C. Post, R. J. Snijder et al., “Grading of pulmonary right-to-left shunt with transthoracic contrast echocardiography: does it predict the indication for embolotherapy?” Chest, vol. 135, no. 5, pp. 1288–1292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Velthuis, E. Buscarini, J. R. Gossage, R. J. Snijder, J. J. Mager, and M. C. Post, “Clinical implications of pulmonary shunting on saline contrast echocardiography,” Journal of the American Society of Echocardiography, vol. 28, no. 3, pp. 255–263, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Rodríguez-Roisin and M. J. Krowka, “Hepatopulmonary syndrome—a liver-induced lung vascular disorder,” The New England Journal of Medicine, vol. 358, no. 22, pp. 2318–2387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Grace and P. W. Angus, “Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment,” Journal of Gastroenterology and Hepatology, vol. 28, no. 2, pp. 213–219, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K. L. Swanson, R. H. Wiesner, and M. J. Krowka, “Natural history of hepatopulmonary syndrome: impact of liver transplantation,” Hepatology, vol. 41, no. 5, pp. 1122–1129, 2005. View at Publisher · View at Google Scholar · View at Scopus